drugset / Trial / NCT07487818

A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation

NCT07487818

Phase 2/3 Recruiting 150 enrolled Mayo Clinic National Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.

Timeline

Start
2026-04-15
Primary completion
2027-01-15
Completion
2027-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 21 mg

Indications

No indication recorded.